|
AMCP - Long-Term Benefits of Rapid Antiretroviral Therapy Initiation Among Medicaid-Covered Patients With
Human Immunodeficiency Virus
|
|
|
Carmela Benson,1 Bruno Emond,2 Hela Romdhani,2 Patrick Lefebvre,2 Aurélie Côté-Sergent,2 Azadeh Shohoudi,2 Neeta Tandon,1 Wing Chow,1 Keith Dunn1
1Janssen Scientific Affairs, LLC, Titusville, NJ, USA; 2Analysis Group, Inc., Montréal, Québec, Canada
Reported by Jules Levin
ACADEMY OF MANAGED CARE & SPECIALTY PHARMACY (AMCP) ANNUAL MEETING; MARCH 25-28, 2019; SAN DIEGO, CALIFORNIA
![0404191](../images/040419/040419-3/0404191.gif)
![0404192](../images/040419/040419-3/0404192.gif)
![0404193](../images/040419/040419-3/0404193.gif)
![0404194](../images/040419/040419-3/0404194.gif)
![0404195](../images/040419/040419-3/0404195.gif)
![0404196](../images/040419/040419-3/0404196.gif)
![0404197](../images/040419/040419-3/0404197.gif)
![0404198](../images/040419/040419-3/0404198.gif)
![0404199](../images/040419/040419-3/0404199.gif)
![04041910](../images/040419/040419-3/04041910.gif)
|
|
|
|
|
|
|